APH AMPHENOL CORP /DE/
APH financial statements, revenue, balance sheet, cash flow, and SEC filings
▼ Company Profile
▼ Key Metrics (TTM)
As of Jun 30, 2026Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| Revenue | $23.09B | $15.22B | $12.55B |
| Cost of Revenue | $14.58B | $10.08B | $8.47B |
| Gross Profit | $8.52B | $5.14B | $4.08B |
| OPERATING EXPENSES | |||
| R&D Expense | $647.00M | $453.00M | $342.20M |
| SG&A Expense | $2.55B | $1.86B | $1.49B |
| Other Operating Expenses (derived) | $-543.60M | $-325.60M | $-307.60M |
| Operating Income | $5.87B | $3.16B | $2.56B |
| NON-OPERATING INCOME / EXPENSE | |||
| Interest Expense | - | - | $139.50M |
| Other Income/Expense | $99.90M | $72.00M | $29.30M |
| Pretax Income | $5.60B | $3.01B | $2.45B |
| Income Tax | $1.30B | $570.30M | $509.30M |
| Net Income | $4.27B | $2.42B | $1.93B |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $3.34 | $1.92 | $1.55 |
| Diluted Shares | 1.28B | 1.26B | 1.24B |
| EBITDA | $6.79B | $3.73B | $2.97B |
| Depreciation & Amortization | $922.40M | $572.50M | $406.40M |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $11.13B | $3.32B | $1.48B |
| Short-term Investments | $303.60M | $18.40M | $185.20M |
| Accounts Receivable | $4.72B | $3.29B | $2.62B |
| Inventory | $3.42B | $2.55B | $2.17B |
| Other Current Assets | $691.00M | $517.00M | $389.60M |
| Current Assets | $20.27B | $9.69B | $6.84B |
| PP&E (Net) | $2.31B | $1.71B | $1.31B |
| Goodwill | $10.58B | $8.24B | $7.09B |
| Intangible Assets | $2.24B | $1.23B | $834.80M |
| Other Noncurrent Assets | $847.30M | $581.10M | $449.20M |
| Noncurrent Assets | $15.97B | $11.75B | $9.69B |
| Total Assets | $36.24B | $21.44B | $16.53B |
| LIABILITIES | |||
| Accounts Payable | $2.66B | $1.82B | $1.35B |
| Other Current Liabilities | $1.65B | $934.40M | $737.50M |
| Current Liabilities | $6.80B | $4.08B | $3.15B |
| Other Noncurrent Liabilities | $788.50M | $509.40M | $453.70M |
| Noncurrent Liabilities | $15.92B | $7.50B | $4.95B |
| Total Liabilities | $22.73B | $11.58B | $8.10B |
| EQUITY | |||
| Common Stock | $1.20M | $1.20M | $1.20M |
| Additional Paid-in Capital | $4.23B | $3.60B | $3.10B |
| Retained Earnings | $9.85B | $7.11B | $5.92B |
| Accumulated OCI | $-479.50M | $-716.30M | $-533.60M |
| Total Equity | $13.50B | $9.85B | $8.40B |
| Temporary Equity | $9.30M | $8.70M | $30.70M |
| Total Liabilities & Equity | $36.24B | $21.44B | $16.53B |
| SUPPLEMENTAL | |||
| Shares Outstanding | 1.23B | 1.21B | 1.20B |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $5.37B | $2.81B | $2.53B |
| Capital Expenditures | $996.60M | $665.40M | $372.80M |
| Cash from Investing | $-5.08B | $-2.65B | $-1.39B |
| Cash from Financing | $7.42B | $1.73B | $-1.01B |
| Free Cash Flow | $4.38B | $2.15B | $2.16B |
| Beginning Cash (CFS) | $3.32B | $1.48B | $1.37B |
| Net Change in Cash | $7.72B | $1.90B | $122.60M |
| Effect of FX on Cash | $97.80M | $-54.00M | $-20.70M |
| Calculated Ending Cash | $11.13B | $3.32B | $1.48B |
| Cash per BS | $11.13B | $3.32B | $1.48B |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $11.13B | $3.32B | $1.48B |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log InQuarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
What is AMPHENOL CORP /DE/'s annual revenue?
AMPHENOL CORP /DE/ reported $29.01B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.
Is AMPHENOL CORP /DE/ profitable?
Yes. AMPHENOL CORP /DE/ reported $5.14B in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.
Does AMPHENOL CORP /DE/ generate free cash flow?
Yes. Free cash flow was $4.71B for trailing twelve months. Operating cash flow was $5.87B.
Fundamentals Hub